Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02334215 · ClinicalTrials.gov registry record · NA

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail

A NA study of Opioid Use Disorder, sponsored by Friends Research Institute.

Completed
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT02334215: Completed NA study of Opioid Use Disorder, sponsored by Friends Research Institute.

NCT02334215 is a NA study of Opioid Use Disorder that has completed, run by Friends Research Institute. The registered enrollment target is 225 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02334215, a NA study of Opioid Use Disorder, has completed, sponsored by Friends Research Institute.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine which of three approaches started in jail is more effective in treating opioid use disorder: (1) methadone treatment without counseling (termed interim methadone) coupled with case management (termed patient navigation); (2) interim methadone without patient navigation; (3) or an enhanced treatment as usual including opioid detoxification, overdose prevention and drug treatment information and referral.

Primary Outcome

Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder)

Conditions Studied

Interventions

  • DRUG Methadone
  • BEHAVIORAL Patient Navigation
  • BEHAVIORAL Enhanced Treatment as Usual (ETAU)

Study Locations (1)

Maryland

  • Baltimore City Detention Center - Baltimore

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2014-12-15
Est. Completion 2020-05
Phase NA
Friends Research Institute

41 total trials

What the finished NCT02334215 record still lists

NCT02334215 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Methadone is the first listed.

NCT02334215 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02334215 about?

NCT02334215 is a clinical study titled "A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail". The purpose of this study is to determine which of three approaches started in jail is more effective in treating opioid use disorder: (1) methadone treatment without counseling (termed interim methadone) coupled with case management (termed patient navigation); (2) interim methadone without patient...

What is the current status of trial NCT02334215?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2014-12-15. Estimated completion is 2020-05.

What conditions does trial NCT02334215 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT02334215?

The interventions under investigation include: Methadone (DRUG), Patient Navigation (BEHAVIORAL), Enhanced Treatment as Usual (ETAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02334215?

This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02334215 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02334215's enrollment target sits among peer trials

225 82nd of 257 higher than 173 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

  • NCT05190679 · 225 participants

    Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02334215, the US trial registry maintained by the National Library of Medicine. NCT02334215 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.